Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,672 | 21 | 35.2% |
| Travel and Lodging | $55,043 | 42 | 33.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $47,519 | 10 | 28.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,700 | 1 | 1.6% |
| Food and Beverage | $1,772 | 40 | 1.1% |
| Honoraria | $750.00 | 1 | 0.4% |
| Education | $420.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $91,617 | 60 | $0 (2022) |
| Shionogi Inc | $43,080 | 40 | $0 (2024) |
| Astellas Pharma Inc | $24,911 | 5 | $0 (2017) |
| Gilead Sciences, Inc. | $3,230 | 1 | $0 (2024) |
| La Jolla Pharmaceutical Company | $2,882 | 2 | $0 (2023) |
| Meitheal Pharmaceuticals, Inc. | $830.19 | 2 | $0 (2024) |
| The Medicines Company | $117.59 | 2 | $0 (2017) |
| SCYNEXIS, Inc. | $92.87 | 2 | $0 (2022) |
| Melinta Therapeutics, Inc. | $88.02 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $27.78 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,895 | 5 | Shionogi Inc ($8,835) |
| 2023 | $5,609 | 4 | La Jolla Pharmaceutical Company ($2,882) |
| 2022 | $19,416 | 19 | Merck Sharp & Dohme LLC ($17,973) |
| 2021 | $6,105 | 3 | Shionogi Inc ($3,900) |
| 2020 | $7,250 | 3 | Merck Sharp & Dohme Corporation ($5,950) |
| 2019 | $39,174 | 29 | Merck Sharp & Dohme Corporation ($27,380) |
| 2018 | $36,068 | 40 | Merck Sharp & Dohme Corporation ($23,183) |
| 2017 | $40,359 | 13 | Astellas Pharma Inc ($24,911) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Meitheal Pharmaceuticals, Inc. | — | Honoraria | Cash or cash equivalent | $750.00 | General |
| 10/18/2024 | Meitheal Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $80.19 | General |
| 10/15/2024 | Shionogi Inc | Fetroja (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $8,818.08 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/25/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/29/2024 | Gilead Sciences, Inc. | AmBisome (Drug) | Consulting Fee | Cash or cash equivalent | $3,230.00 | General |
| Category: OTHER | ||||||
| 10/14/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $27.78 | General |
| 10/11/2023 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Consulting Fee | Cash or cash equivalent | $2,680.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2023 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Consulting Fee | In-kind items and services | $201.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/13/2023 | Shionogi Inc | Fetroja (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/19/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $76.11 | General |
| 10/19/2022 | SCYNEXIS, Inc. | — | Food and Beverage | In-kind items and services | $16.76 | General |
| 07/21/2022 | Shionogi Inc | Fetroja (Drug) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/02/2022 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,580.00 | General |
| 05/02/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 04/27/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 04/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Travel and Lodging | In-kind items and services | $6,914.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $421.31 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Travel and Lodging | In-kind items and services | $157.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Travel and Lodging | In-kind items and services | $66.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/24/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Travel and Lodging | In-kind items and services | $19.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/23/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Travel and Lodging | In-kind items and services | $157.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/23/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $55.42 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/23/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/22/2022 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Travel and Lodging | In-kind items and services | $157.41 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. Cornelius Clancy, MD
Dr. Cornelius Clancy, MD is a Infectious Disease healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326075094.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cornelius Clancy, MD has received a total of $166,876 in payments from pharmaceutical and medical device companies, with $12,895 received in 2024. These payments were reported across 116 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($58,672).
Practice Information
- Specialty Infectious Disease
- Location Gainesville, FL
- Active Since 06/27/2006
- Last Updated 02/14/2008
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1326075094
Products in Payments
- Fetroja (Drug) $29,878
- Micafungin (Drug) $24,911
- ZERBAXA (Drug) $15,467
- AmBisome (Drug) $3,230
- XACDURO (Drug) $2,882
- VABOMERE (Drug) $117.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Gainesville
Lennox Archibald, Md, MD
Infectious Disease — Payments: $2.9M
Adam Bressler, M.d, M.D
Infectious Disease — Payments: $123,008
Wendy Garlington, Md, MD
Infectious Disease — Payments: $1,427
Gary Wang, Md, Phd, MD, PHD
Infectious Disease — Payments: $850.64
Marie Kima, M.d, M.D
Infectious Disease — Payments: $749.97
Dr. Guy El Helou, M.d, M.D
Infectious Disease — Payments: $656.94